The problem is the population and amount of disease. Its still v expensive to run these trials in Australia and the trial may go on for 3-5 years to get the population data...
No problems but you need money to run the trial and right now we have none, no confidence, and an IP that looks useless.
Unless they co-sign with a major pharmaceutical company, we are a sitting duck.....
Australia, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
